These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Rhee SH; Im E; Riegler M; Kokkotou E; O'brien M; Pothoulakis C Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13610-5. PubMed ID: 16157881 [TBL] [Abstract][Full Text] [Related]
47. Role of interferon-γ and inflammatory monocytes in driving colonic inflammation during acute Clostridium difficile infection in mice. McDermott AJ; Falkowski NR; McDonald RA; Frank CR; Pandit CR; Young VB; Huffnagle GB Immunology; 2017 Apr; 150(4):468-477. PubMed ID: 27995603 [TBL] [Abstract][Full Text] [Related]
48. Human Plasminogen Exacerbates Clostridioides difficile Enteric Disease and Alters the Spore Surface. Awad MM; Hutton ML; Quek AJ; Klare WP; Mileto SJ; Mackin K; Ly D; Oorschot V; Bosnjak M; Jenkin G; Conroy PJ; West N; Fulcher A; Costin A; Day CJ; Jennings MP; Medcalf RL; Sanderson-Smith M; Cordwell SJ; Law RHP; Whisstock JC; Lyras D Gastroenterology; 2020 Oct; 159(4):1431-1443.e6. PubMed ID: 32574621 [TBL] [Abstract][Full Text] [Related]
49. Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Ortega-Cava CF; Ishihara S; Rumi MA; Aziz MM; Kazumori H; Yuki T; Mishima Y; Moriyama I; Kadota C; Oshima N; Amano Y; Kadowaki Y; Ishimura N; Kinoshita Y Clin Vaccine Immunol; 2006 Jan; 13(1):132-8. PubMed ID: 16426010 [TBL] [Abstract][Full Text] [Related]
50. Development of a Standardized Scoring System to Assess a Murine Model of Shelby RD; Tengberg N; Conces M; Olson JK; Navarro JB; Bailey MT; Goodman SD; Besner GE J Invest Surg; 2020 Dec; 33(10):887-895. PubMed ID: 30892111 [No Abstract] [Full Text] [Related]
51. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model. Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751 [TBL] [Abstract][Full Text] [Related]
52. Host recognition of Clostridium difficile and the innate immune response. Cowardin CA; Petri WA Anaerobe; 2014 Dec; 30():205-9. PubMed ID: 25223264 [TBL] [Abstract][Full Text] [Related]
53. Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile. Bruxelle JF; Mizrahi A; Hoÿs S; Collignon A; Janoir C; Péchiné S PLoS One; 2017; 12(11):e0187212. PubMed ID: 29176760 [TBL] [Abstract][Full Text] [Related]
54. Deletion of TLR5 results in spontaneous colitis in mice. Vijay-Kumar M; Sanders CJ; Taylor RT; Kumar A; Aitken JD; Sitaraman SV; Neish AS; Uematsu S; Akira S; Williams IR; Gewirtz AT J Clin Invest; 2007 Dec; 117(12):3909-21. PubMed ID: 18008007 [TBL] [Abstract][Full Text] [Related]
55. The American Cockroach Peptide Periplanetasin-2 Blocks Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695 [No Abstract] [Full Text] [Related]
56. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury. Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780 [TBL] [Abstract][Full Text] [Related]
57. Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Lawley TD; Clare S; Walker AW; Goulding D; Stabler RA; Croucher N; Mastroeni P; Scott P; Raisen C; Mottram L; Fairweather NF; Wren BW; Parkhill J; Dougan G Infect Immun; 2009 Sep; 77(9):3661-9. PubMed ID: 19564382 [TBL] [Abstract][Full Text] [Related]